文献速递胃肠动力与功能性疾病

健康成人糖探针法检测小肠与结肠通透性的建立与验证

Development and Validation of Test for "Leaky Gut" Small Intestinal and Colonic Permeability Using Sugars in Healthy Adults.
PubMed 文献 · Gastroenterology · 2021-04-16

结果显示13C-甘露醇主要反映小肠通透性,个体内一致,个体间变异较大;12C-甘露醇基线排泄高不宜作探针,13C-甘露醇为优选探针,且在腹泻型肠易激综合征患者中可行。

要点

  • 13C-甘露醇是评价小肠通透性的优选探针。
  • 12C-甘露醇因基线排泄高不适合作为探针使用。
  • 健康成人通透性测量个体内一致,个体间变异较大。

核心结论

  • 12C-甘露醇基线排泄使其不可用,13C-甘露醇是评价小肠通透性的优选探针。

研究设计与样本

  • 每次测试口服12C-甘露醇、13C-甘露醇、鼠李糖、三氯蔗糖与乳果糖,并行3段尿液收集。
  • 18例腹泻型肠易激综合征患者接受口服13C-甘露醇与乳果糖后24小时排泄研究。

主要发现

  • 13C-甘露醇、鼠李糖、乳果糖与三氯蔗糖的24小时中位排泄(占给药剂量百分比)分别约为30%、约15%、0.32%与2.3%。
  • 13C-甘露醇与鼠李糖主要反映小肠通透性。
  • 个体内糖排泄一致,16.25g与32.5g纤维饮食间差异较小。
  • 个体间变异系数中位数为76.5%(10-90百分位:34.6-111.0)。
  • 健康人群中性别、年龄或体重指数对通透性测量无显著影响。

关键数值与推荐

  • 基线糖浓度超过定量下限3倍以上者:12C-甘露醇见于所有参与者,三氯蔗糖见于4-8人,鼠李糖见于1-3人。

临床怎么用

  • 临床可采用13C-甘露醇作为小肠通透性探针,避免使用12C-甘露醇。
  • 在腹泻型肠易激综合征患者中,13C-甘露醇测量可行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oral monosaccharides and disaccharides are used to measure in vivo human gut permeability through urinary excretion. AIMS: The aims were as follows: (1) to obtain normative data on small intestinal and colonic permeability; (2) to assess variance on standard 16 g fiber diet performed twice; (3) to determine whether dietary fiber influences gut permeability measurements; and (4) to present pilot data using 2 selected probes in patients with diarrhea-predominant irritable bowel syndrome (IBS-D). METHODS: Sixty healthy female and male adults, age 18-70 years, participated in 3 randomized studies (2 studies on 16.25 g and 1 study on 32.5 g fiber) in otherwise standardized diets. At each test, the following sugars were ingested: 12C-mannitol, 13C-mannitol, rhamnose (monosaccharides), sucralose, and lactulose (disaccharides). Standardized meals were administered from 24 hours before and during 24 hours post-sugars with 3 urine collections: 0-2, 2-8, and 8-24 hours. Sugars were measured using high-performance liquid chromatography-tandem mass spectrometry. Eighteen patients with IBS-D underwent 24-hour excretion studies after oral 13C-mannitol and lactulose. RESULTS: Baseline sugars (>3-fold above lower limits of quantitation) were identified in the 3 studies: 12C-mannitol in all participants; sucralose in 4-8, and rhamnose in 1-3. Median excretions/24 h (percentage of administered dose) for 13C-mannitol, rhamnose, lactulose, and sucralose were ∼30%, ∼15%, 0.32%, and 2.3%, respectively. 13C-mannitol and rhamnose reflected mainly small intestinal permeability. Intraindividual saccharide excretions were consistent, with minor differences with 16.25 g vs 32.5 g fiber diets. Median interindividual coefficient of variation was 76.5% (10-90 percentile: 34.6-111.0). There were no significant effects of sex, age, or body mass index on permeability measurements in health. 13C-mannitol measurements are feasible in IBS-D. CONCLUSIONS: Baseline 12C-mannitol excretion precludes its use; 13C-mannitol is the preferred probe for small intestinal permeability.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Khoshbin K, Khanna L, Maselli D, et al. Development and Validation of Test for "Leaky Gut" Small Intestinal and Colonic Permeability Using Sugars in Healthy Adults. Gastroenterology. 2021. PMID: 33865841. doi:10.1053/j.gastro.2021.04.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。